Home › Research › Brain scans and imaging
Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia
Anor CJ, O'Connor S, Saund A, Tang-Wai DF, Keren R, Tartaglia MC.. Neuro-degenerative diseases, 2017-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background/aims Neuropsychiatric symptoms (NPS) are common in Alzheimer disease (AD) and vascular dementia (VaD), and are distressful to patients and caregivers. NPS are likely related to the underlying pathology. Previous studies suggest that frontal lobe lesions and vascular changes such as white matter hyperintensities (WMH) have a significant association with specific NPS. The current study aimed to compare NPS in patients with AD, VaD, and mixed AD/VaD, and to evaluate the differences in the prevalence of NPS in relation to frontal WMH volume. Methods In total, 180 patients with NPS and MRI data (92 probable AD, 51%; 34 probable VaD, 19%; and 54 probable mixed AD/VaD, 30%) were included in the study. Regression analyses were performed to determine the relationships between NPS prevalence and diagnosis, and between NPS and frontal WMH. Results VaD patients had significantly more agitation (p Conclusion Differences in NPS prevalence are likely related to the underlying pathology and warrant further study as they have implications for treatment.
What this study adds
Evidence grade: Low
The record lists 180 participants. Comparing patients with Alzheimer disease, vascular dementia and mixed dementia, those with vascular dementia had significantly more agitation, and differences in neuropsychiatric symptoms were likely related to the underlying pathology. The authors conclude these differences need further study because they have implications for treatment, but no treatment itself was tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Anor, C. J., O'Connor, S., Saund, A., Tang-Wai, D. F., Keren, R., & Tartaglia, M. C. (2017). Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia. Neuro-degenerative diseases. https://doi.org/10.1159/000455127
Vancouver
Anor CJ, O'Connor S, Saund A, Tang-Wai DF, Keren R, Tartaglia MC. Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia. Neuro-degenerative diseases. 2017. doi:10.1159/000455127. PMID: 28245482.
BibTeX
@article{anor2017-28245482,
author = {Anor, C. J. and O'Connor, S. and Saund, A. and Tang-Wai, D. F. and Keren, R. and Tartaglia, M. C.},
title = {{Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia}},
journal = {Neuro-degenerative diseases},
year = {2017},
doi = {10.1159/000455127},
pmid = {28245482},
url = {https://doi.org/10.1159/000455127}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Previous studies suggest that frontal lobe lesions and vascular changes such as white matter hyperintensities (WMH) have a significant association with specific NPS.
- Results VaD patients had significantly more agitation (p Conclusion Differences in NPS prevalence are likely related to the underlying pathology and warrant further study as they have implications for treatment.
Why it matters
Comparing patients with Alzheimer disease, vascular dementia and mixed dementia, those with vascular dementia had significantly more agitation, and differences in neuropsychiatric symptoms were likely related to the underlying pathology. The authors conclude these differences need further study because they have implications for treatment, but no treatment itself was tested.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Participants180
- Evidence strengthLow
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 46 of the 96 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuro-degenerative diseases) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 180 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 86 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.8 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 3 / 6 | Cited 4.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 2 / 4 | Cited 22 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Maria Carmela Tartaglia: h-index 64 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Toronto: institution h-index 1,923 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28245482) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 46 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 46 of the 96 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Brain scans and imaging from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.